Loading...
Cancer stem cells in neuroblastoma therapy resistance
Neuroblastoma (NB) is the most common cancer of infancy and accounts for nearly one tenth of pediatric cancer deaths. This mortality rate has been attributed to the > 50% frequency of relapse despite intensive, multimodal clinical therapy in patients with progressive NB. Given the disease’s heter...
Na minha lista:
| Udgivet i: | Cancer Drug Resist |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
OAE Publishing Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6924637/ https://ncbi.nlm.nih.gov/pubmed/31867574 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20517/cdr.2019.72 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|